UCD neurosurgery

In the antiseptic language of government documents, she was identified only as Patient No. 2, a dying woman who agreed to undergo an experimental procedure at the UC Davis Medical Center.

Federal regulators have backed off their threat to cut funding to the UC Davis Medical Center after a follow-up inspection found that the public hospital is now complying with regulations governing patient safety and care.

Nurses weren't told what was going on in the operating room. Top hospital leaders were kept in the dark, or avoided asking questions. Hospital policies and federal regulations were violated.

Federal regulators identified "serious deficiencies" at the UC Davis Medical Center, related to three patient deaths in 2010 and 2011.

56-year-old man admitted to hospital Oct. 14, 2010.

A team of eight inspectors arrived unannounced Monday for a floor-by-floor survey of the UC Davis Medical Center, part of a widening probe of the hospital over untested surgical procedures performed by two neurosurgeons on three terminally ill patients who later died.

In a scathing review of three experimental surgeries at the UC Davis Medical Center, federal regulators found that deficiencies were so severe the 619-bed hospital "lacks the capacity to render adequate care to patients."

The UC Davis neurosurgeon at the center of a widening scandal over his experimental treatments of dying brain cancer patients is taking a leave of absence from the medical center staff, a university official announced Thursday.

Amid scrutiny from federal regulators and her own administration, the dean of the UC Davis School of Medicine announced Monday she will be stepping down.

The controversial activities of two UC Davis neurosurgeons have triggered another investigation into patient safety and care at the university hospital, this time by the independent, nonprofit body that accredits hospitals nationwide, The Bee has learned.

A federal watchdog agency has initiated an investigation into the care of three UC Davis patients who died after undergoing experimental treatments for brain cancer.

Fifteen years after his arrival at UC Davis, Dr. J. Paul Muizelaar now finds himself the focus of a university investigation into his experimental treatments of dying brain cancer patients.

A UC Davis neurosurgeon accused of performing unauthorized research on humans has "temporarily relinquished" his position as chairman of the department of neurological surgery, the university confirmed Friday.

UC Davis Chancellor Linda P.B. Katehi has directed the university's provost to conduct a comprehensive review of the events that led to a research ban for the head of the neurological surgery department. But so far Dr. J. Paul Muizelaar retains his position as department chairman. Why?

UC Davis Chancellor Linda P.B. Katehi has ordered a top campus official to conduct a "comprehensive review" of accusations that two university neurosurgeons conducted unauthorized research on dying brain cancer patients, as reported in Sunday's Bee.

In 2010 – the same year Dr. J. Paul Muizelaar first performed an experimental treatment on a dying brain cancer patient at UC Davis Medical Center – the neurosurgeon made more money than 99.9 percent of all employees in the University of California system.

A prominent UC Davis neurosurgeon was banned from performing medical research on humans after he and an underling were accused of experimenting on dying brain cancer patients without university permission, The Bee has learned.